These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1784581)

  • 1. Matrix type controlled release systems: I. Effect of percolation on drug dissolution kinetics.
    Bonny JD; Leuenberger H
    Pharm Acta Helv; 1991; 66(5-6):160-4. PubMed ID: 1784581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
    Fuertes I; Miranda A; Millán M; Caraballo I
    Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percolative drug diffusion from cylindrical matrix systems with unsealed boundaries.
    Brohede U; Valizadeh S; Strømme M; Frenning G
    J Pharm Sci; 2007 Nov; 96(11):3087-99. PubMed ID: 17721939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion.
    Crowley MM; Schroeder B; Fredersdorf A; Obara S; Talarico M; Kucera S; McGinity JW
    Int J Pharm; 2004 Jan; 269(2):509-22. PubMed ID: 14706261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of controlled release inert matrices of naltrexone hydrochloride based on percolation concepts.
    Caraballo I; Melgoza LM; Alvarez-Fuentes J; Soriano MC; Rabasco AM
    Int J Pharm; 1999 Apr; 181(1):23-30. PubMed ID: 10370199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.
    Miranda A; Millán M; Caraballo I
    J Pharm Sci; 2007 Oct; 96(10):2746-56. PubMed ID: 17506514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the percolation thresholds in lobenzarit disodium native dextran matrix tablets.
    Gil EC; Colarte AI; Bataille B; Caraballo I
    AAPS PharmSciTech; 2007 Dec; 8(4):E115. PubMed ID: 18181536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of percolation theory in the study of an extended release Verapamil hydrochloride formulation.
    Gonçalves-Araújo T; Rajabi-Siahboomi AR; Caraballo I
    Int J Pharm; 2008 Sep; 361(1-2):112-7. PubMed ID: 18621491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanofibrillar cellulose films for controlled drug delivery.
    Kolakovic R; Peltonen L; Laukkanen A; Hirvonen J; Laaksonen T
    Eur J Pharm Biopharm; 2012 Oct; 82(2):308-15. PubMed ID: 22750440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spray-dried nanofibrillar cellulose microparticles for sustained drug release.
    Kolakovic R; Laaksonen T; Peltonen L; Laukkanen A; Hirvonen J
    Int J Pharm; 2012 Jul; 430(1-2):47-55. PubMed ID: 22465549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Release from Inert Spherical Matrix Systems Using Monte Carlo Simulations.
    Villalobos R; Garcia EV; Quintanar D; Young PM
    Curr Drug Deliv; 2017; 14(1):65-72. PubMed ID: 27174175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo simulations for the study of drug release from cylindrical matrix systems with an inert nucleus.
    Martínez L; Villalobos R; Sánchez M; Cruz J; Ganem A; Melgoza LM
    Int J Pharm; 2009 Mar; 369(1-2):38-46. PubMed ID: 19027839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of saccharides from matrix tablets.
    Mäki R; Suihko E; Korhonen O; Pitkänen H; Niemi R; Lehtonen M; Ketolainen J
    Eur J Pharm Biopharm; 2006 Feb; 62(2):163-70. PubMed ID: 16343875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictability of drug release from water-insoluble polymeric matrix tablets.
    Grund J; Körber M; Bodmeier R
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):650-5. PubMed ID: 23985775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of matrix tablets controlled drug release using Elman dynamic neural networks and decision trees.
    Petrović J; Ibrić S; Betz G; Đurić Z
    Int J Pharm; 2012 May; 428(1-2):57-67. PubMed ID: 22402474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies.
    Obeidat WM; Alzoubi NM
    Pharmazie; 2014 Feb; 69(2):96-103. PubMed ID: 24640597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.